Found 364 hits of ic50 data for polymerid = 1810,50000181 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50246899
((S)-2-(3-((S)-1-carboxy-5-(4-iodobenzamido)pentyl)...)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)c1ccc(I)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C19H24IN3O8/c20-12-6-4-11(5-7-12)16(26)21-10-2-1-3-13(17(27)28)22-19(31)23-14(18(29)30)8-9-15(24)25/h4-7,13-14H,1-3,8-10H2,(H,21,26)(H,24,25)(H,27,28)(H,29,30)(H2,22,23,31)/t13-,14-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
Patents
Similars
| MMDB PDB Article PubMed
| n/a | n/a | 0.0210 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468173
(CHEMBL4284995)Show SMILES CN(C(=O)CCC[C@H](NC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O)c1ccc(F)nc1 |r| Show InChI InChI=1S/C18H23FN4O8/c1-23(10-5-7-13(19)20-9-10)14(24)4-2-3-11(16(27)28)21-18(31)22-12(17(29)30)6-8-15(25)26/h5,7,9,11-12H,2-4,6,8H2,1H3,(H,25,26)(H,27,28)(H,29,30)(H2,21,22,31)/t11-,12-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid PDB UniChem
| PDB Article PubMed
| n/a | n/a | 0.0750 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2 [44-750]
(Homo sapiens (Human)) | BDBM17759
((2S)-2-(phosphonomethyl)pentanedioic acid | (S)-2-...)Show InChI InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13)/t4-/m1/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Similars
| MMDB PDB Article PubMed
| n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Guilford
| Assay Description GCPII activity in vitro is monitored through the hydrolysis [3H]NAAG to NAA and [3H]Glu. The radioactivity-based assay was miniaturized to a 96-well ... |
J Med Chem 48: 2319-24 (2005)
Article DOI: 10.1021/jm049258g BindingDB Entry DOI: 10.7270/Q2D50K77 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468167
(CHEMBL4280968)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)N(CCNC(=O)c1ccc(F)nc1)c1ccccc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C26H30FN5O9/c27-20-11-9-16(15-29-20)23(36)28-13-14-32(17-5-2-1-3-6-17)21(33)8-4-7-18(24(37)38)30-26(41)31-19(25(39)40)10-12-22(34)35/h1-3,5-6,9,11,15,18-19H,4,7-8,10,12-14H2,(H,28,36)(H,34,35)(H,37,38)(H,39,40)(H2,30,31,41)/t18-,19-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid PDB UniChem
| PDB Article PubMed
| n/a | n/a | 0.130 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468163
(CHEMBL4286872)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)N(CCNC(=O)c1ccc(F)cc1)c1ccccc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C27H31FN4O9/c28-18-11-9-17(10-12-18)24(36)29-15-16-32(19-5-2-1-3-6-19)22(33)8-4-7-20(25(37)38)30-27(41)31-21(26(39)40)13-14-23(34)35/h1-3,5-6,9-12,20-21H,4,7-8,13-16H2,(H,29,36)(H,34,35)(H,37,38)(H,39,40)(H2,30,31,41)/t20-,21-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 0.150 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468164
(CHEMBL4288368)Show SMILES CN(C(=O)CCC[C@H](NC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O)c1ccc(F)cc1 |r| Show InChI InChI=1S/C19H24FN3O8/c1-23(12-7-5-11(20)6-8-12)15(24)4-2-3-13(17(27)28)21-19(31)22-14(18(29)30)9-10-16(25)26/h5-8,13-14H,2-4,9-10H2,1H3,(H,25,26)(H,27,28)(H,29,30)(H2,21,22,31)/t13-,14-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 0.200 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50246899
((S)-2-(3-((S)-1-carboxy-5-(4-iodobenzamido)pentyl)...)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)c1ccc(I)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C19H24IN3O8/c20-12-6-4-11(5-7-12)16(26)21-10-2-1-3-13(17(27)28)22-19(31)23-14(18(29)30)8-9-15(24)25/h4-7,13-14H,1-3,8-10H2,(H,21,26)(H,24,25)(H,27,28)(H,29,30)(H2,22,23,31)/t13-,14-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL MMDB PC cid PC sid PDB UniChem
Patents
Similars
| MMDB PDB Article PubMed
| n/a | n/a | 0.220 | n/a | n/a | n/a | n/a | n/a | n/a |
Korea University
Curated by ChEMBL
| Assay Description Inhibition of PSMA in human LNCaP cell extracts in presence of N-acetylaspartylglutamate by Amplex red glutamic acid dependent fluorescence-based NAA... |
J Med Chem 63: 3261-3273 (2020)
Article DOI: 10.1021/acs.jmedchem.9b02022 BindingDB Entry DOI: 10.7270/Q232007C |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468174
(CHEMBL4277729)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)Nc1cccc(F)c1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C18H22FN3O8/c19-10-3-1-4-11(9-10)20-14(23)6-2-5-12(16(26)27)21-18(30)22-13(17(28)29)7-8-15(24)25/h1,3-4,9,12-13H,2,5-8H2,(H,20,23)(H,24,25)(H,26,27)(H,28,29)(H2,21,22,30)/t12-,13-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 0.280 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM17659
((R,S)-2-phosphonomethylpentanedioic acid | 2-(phos...)Show InChI InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Notre Dame
Curated by ChEMBL
| Assay Description Inhibition of human recombinant NAALADase |
Bioorg Med Chem 16: 1648-57 (2008)
Article DOI: 10.1016/j.bmc.2007.11.030 BindingDB Entry DOI: 10.7270/Q2MC90VM |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM17659
((R,S)-2-phosphonomethylpentanedioic acid | 2-(phos...)Show InChI InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Johns Hopkins School of Medicine
Curated by ChEMBL
| Assay Description Inhibition of GCP-2 (unknown origin) |
Drug Metab Dispos 40: 2315-23 (2012)
Article DOI: 10.1124/dmd.112.046821 BindingDB Entry DOI: 10.7270/Q2W66NG5 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM17659
((R,S)-2-phosphonomethylpentanedioic acid | 2-(phos...)Show InChI InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Guilford Pharmaceuticals Inc.
Curated by ChEMBL
| Assay Description Inhibition of N-acetyl-L-aspartyl-[3H]-L-glutamate binding to glutamate carboxypeptidase II (GCP II) |
J Med Chem 46: 1989-96 (2003)
Article DOI: 10.1021/jm020515w BindingDB Entry DOI: 10.7270/Q2SQ8ZRG |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM17659
((R,S)-2-phosphonomethylpentanedioic acid | 2-(phos...)Show InChI InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
Guilford Pharmaceuticals Inc.
Curated by ChEMBL
| Assay Description Inhibition of Glutamate carboxypeptidase II |
Bioorg Med Chem Lett 13: 2097-100 (2003)
BindingDB Entry DOI: 10.7270/Q2Z60NF2 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2 [44-750]
(Homo sapiens (Human)) | BDBM17659
((R,S)-2-phosphonomethylpentanedioic acid | 2-(phos...)Show InChI InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | 7.4 | 37 |
MGI Pharma
| Assay Description GCPII activity in vitro is monitored through the hydrolysis [3H]NAAG to NAA and [3H]Glu. The radioactivity-based assay was miniaturized to a 96-well ... |
J Med Chem 49: 2876-85 (2006)
Article DOI: 10.1021/jm051019l BindingDB Entry DOI: 10.7270/Q28C9TJD |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2 [44-750]
(Homo sapiens (Human)) | BDBM17659
((R,S)-2-phosphonomethylpentanedioic acid | 2-(phos...)Show InChI InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | 7.4 | 37 |
NCI-FCRDC
| Assay Description The inhibition concentration values of GCPII were determined using the radioenzymatic assay with [3H] NAAG (radiolabeled on the terminal glutamate). ... |
J Med Chem 50: 3267-73 (2007)
Article DOI: 10.1021/jm070133w BindingDB Entry DOI: 10.7270/Q29C6VPS |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2 [44-750]
(Homo sapiens (Human)) | BDBM17659
((R,S)-2-phosphonomethylpentanedioic acid | 2-(phos...)Show InChI InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | 7.4 | 37 |
Guilford
| Assay Description GCPII activity in vitro is monitored through the hydrolysis [3H]NAAG to NAA and [3H]Glu. The radioactivity-based assay was miniaturized to a 96-well ... |
J Med Chem 48: 2319-24 (2005)
Article DOI: 10.1021/jm049258g BindingDB Entry DOI: 10.7270/Q2D50K77 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468175
(CHEMBL4291782)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)Nc1ccc(F)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C18H22FN3O8/c19-10-4-6-11(7-5-10)20-14(23)3-1-2-12(16(26)27)21-18(30)22-13(17(28)29)8-9-15(24)25/h4-7,12-13H,1-3,8-9H2,(H,20,23)(H,24,25)(H,26,27)(H,28,29)(H2,21,22,30)/t12-,13-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid PDB UniChem
| PDB Article PubMed
| n/a | n/a | 0.350 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50358646
(CHEMBL1921899)Show SMILES OC(=O)CC[C@H](NP(O)(=O)OC[C@H](NC(=O)CC[C@H](NC(=O)CCCCCNC(=O)c1ccc(c(c1)C(O)=O)-c1c2ccc(O)cc2oc2cc(=O)ccc12)C(O)=O)C(O)=O)C(O)=O |r,wD:18.18,12.12,5.5,(26.08,-15.33,;26.07,-13.79,;27.4,-13.02,;24.72,-13.04,;23.39,-13.81,;22.06,-13.06,;20.73,-13.83,;19.39,-13.07,;19.38,-14.61,;18.06,-13.85,;19.38,-11.53,;18.04,-10.77,;18.03,-9.23,;16.69,-8.47,;15.36,-9.24,;15.38,-10.78,;14.02,-8.49,;12.7,-9.26,;11.36,-8.51,;10.03,-9.28,;8.69,-8.52,;8.68,-6.98,;7.36,-9.3,;6.02,-8.54,;4.69,-9.32,;3.36,-8.56,;2.03,-9.34,;.68,-8.58,;-.64,-9.35,;-1.98,-8.6,;-.63,-10.89,;-1.96,-11.68,;-1.95,-13.22,;-.62,-13.97,;.71,-13.2,;.71,-11.66,;2.04,-12.42,;3.39,-13.18,;2.04,-10.88,;-.61,-15.51,;-1.93,-16.3,;-3.27,-15.53,;-4.6,-16.3,;-4.6,-17.85,;-5.93,-18.61,;-3.27,-18.62,;-1.92,-17.84,;-.59,-18.61,;.74,-17.83,;2.07,-18.58,;3.4,-17.81,;4.74,-18.57,;3.39,-16.27,;2.05,-15.51,;.74,-16.28,;11.34,-6.96,;12.68,-6.18,;10.01,-6.2,;19.36,-8.45,;20.7,-9.21,;19.35,-6.91,;22.05,-11.52,;23.38,-10.73,;20.7,-10.75,)| Show InChI InChI=1S/C40H43N4O19P/c45-21-6-9-24-30(17-21)63-31-18-22(46)7-10-25(31)35(24)23-8-5-20(16-26(23)37(52)53)36(51)41-15-3-1-2-4-32(47)42-27(38(54)55)11-13-33(48)43-29(40(58)59)19-62-64(60,61)44-28(39(56)57)12-14-34(49)50/h5-10,16-18,27-29,45H,1-4,11-15,19H2,(H,41,51)(H,42,47)(H,43,48)(H,49,50)(H,52,53)(H,54,55)(H,56,57)(H,58,59)(H2,44,60,61)/t27-,28-,29-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.350 | n/a | n/a | n/a | n/a | n/a | n/a |
Washington State University
Curated by ChEMBL
| Assay Description Inhibition of PSMA using N-[4-(phenylazo)-benzoyl]-glutamyl-gamma-glutamic acid as substrate after 15 mins by HPLC analysis |
Bioorg Med Chem Lett 21: 7013-6 (2011)
Article DOI: 10.1016/j.bmcl.2011.09.115 BindingDB Entry DOI: 10.7270/Q2PG1S5S |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50358645
(CHEMBL1921898)Show SMILES OC(=O)CC[C@H](NP(O)(=O)OC[C@H](NC(=O)CC[C@H](NC(=O)c1ccc(c(c1)C([O-])=O)-c1c2ccc(O)cc2oc2cc(=O)ccc12)C(O)=O)C(O)=O)C(O)=O |r,wU:18.18,wD:12.12,5.5,(11.85,-15.93,;11.85,-14.39,;13.19,-13.62,;10.52,-13.62,;9.19,-14.39,;7.85,-13.62,;6.52,-14.39,;5.19,-13.63,;5.17,-15.16,;3.86,-14.4,;5.19,-12.09,;3.86,-11.32,;3.86,-9.78,;2.52,-9.01,;1.19,-9.78,;1.19,-11.32,;-.14,-9.02,;-1.48,-9.79,;-2.81,-9.02,;-2.81,-7.48,;-4.14,-6.71,;-5.47,-7.48,;-4.14,-5.17,;-5.48,-4.4,;-5.48,-2.87,;-4.14,-2.09,;-2.82,-2.86,;-2.81,-4.39,;-1.48,-2.09,;-.15,-2.85,;-2.58,-.99,;-4.14,-.56,;-5.48,.21,;-6.81,-.55,;-8.14,.22,;-8.14,1.76,;-9.47,2.53,;-6.81,2.53,;-5.48,1.77,;-4.14,2.55,;-2.79,1.77,;-1.46,2.54,;-.13,1.77,;1.2,2.54,;-.12,.22,;-1.46,-.56,;-2.8,.22,;-4.14,-9.79,;-5.47,-9.02,;-4.14,-11.33,;5.18,-9.01,;6.52,-9.78,;5.18,-7.47,;7.85,-12.09,;9.18,-11.31,;6.52,-11.31,)| Show InChI InChI=1S/C34H32N3O18P/c38-16-2-5-19-25(12-16)55-26-13-17(39)3-6-20(26)29(19)18-4-1-15(11-21(18)31(44)45)30(43)36-22(32(46)47)7-9-27(40)35-24(34(50)51)14-54-56(52,53)37-23(33(48)49)8-10-28(41)42/h1-6,11-13,22-24,38H,7-10,14H2,(H,35,40)(H,36,43)(H,41,42)(H,44,45)(H,46,47)(H,48,49)(H,50,51)(H2,37,52,53)/p-1/t22-,23-,24-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.410 | n/a | n/a | n/a | n/a | n/a | n/a |
Washington State University
Curated by ChEMBL
| Assay Description Inhibition of PSMA using N-[4-(phenylazo)-benzoyl]-glutamyl-gamma-glutamic acid as substrate after 15 mins by HPLC analysis |
Bioorg Med Chem Lett 21: 7013-6 (2011)
Article DOI: 10.1016/j.bmcl.2011.09.115 BindingDB Entry DOI: 10.7270/Q2PG1S5S |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468177
(CHEMBL4291245)Show SMILES CN(Cc1cccc(F)c1)C(=O)CCC[C@H](NC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C20H26FN3O8/c1-24(11-12-4-2-5-13(21)10-12)16(25)7-3-6-14(18(28)29)22-20(32)23-15(19(30)31)8-9-17(26)27/h2,4-5,10,14-15H,3,6-9,11H2,1H3,(H,26,27)(H,28,29)(H,30,31)(H2,22,23,32)/t14-,15-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 0.460 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50304738
(2-(3-((S)-1-carboxy-3-methylbutyl)ureido)pentanedi...)Show SMILES CC(C)C[C@H](NC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C12H20N2O7/c1-6(2)5-8(11(19)20)14-12(21)13-7(10(17)18)3-4-9(15)16/h6-8H,3-5H2,1-2H3,(H,15,16)(H,17,18)(H,19,20)(H2,13,14,21)/t7-,8-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Similars
| PDB Article PubMed
| n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Institute of Biotechnology of the Czech Academy of Sciences
Curated by ChEMBL
| Assay Description Inhibition of N-terminally tagged human recombinant GCP2 (44 to 750 residues) extracellular domain expressed in Drosophila melanogaster S2 cells prei... |
Bioorg Med Chem 27: 255-264 (2019)
Article DOI: 10.1016/j.bmc.2018.11.022 BindingDB Entry DOI: 10.7270/Q2F47SC4 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50331102
(2-{[2-(4-Amino-4-carboxy-butyrylamino)-2-carboxyet...)Show SMILES N[C@@H](CCC(=O)N[C@@H](COP([O-])(=O)O[C@@H](CCC(O)=O)C(O)=O)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C13H21N2O13P/c14-6(11(19)20)1-3-9(16)15-7(12(21)22)5-27-29(25,26)28-8(13(23)24)2-4-10(17)18/h6-8H,1-5,14H2,(H,15,16)(H,17,18)(H,19,20)(H,21,22)(H,23,24)(H,25,26)/p-1/t6-,7-,8-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL KEGG PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 0.550 | n/a | n/a | n/a | n/a | n/a | n/a |
Washington State University
Curated by ChEMBL
| Assay Description Inhibition of PSMA in human LNCaP cells |
Bioorg Med Chem Lett 20: 7124-6 (2010)
Article DOI: 10.1016/j.bmcl.2010.09.057 BindingDB Entry DOI: 10.7270/Q2KD1Z57 |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM578389
(US11478558, Compound 1)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCN(Cc1ccc(Br)cc1)C(=O)CCCCNC(=S)Nc1ccc(CC2CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN2CC(O)=O)cc1)C(O)=O)C(O)=O |r| | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.570 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description TBD |
Citation and Details
BindingDB Entry DOI: 10.7270/Q20P138Q |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468178
(CHEMBL4283406)Show SMILES CN(Cc1ccc(F)cc1)C(=O)CCC[C@H](NC(=O)N[C@@H](CCC(O)=O)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C20H26FN3O8/c1-24(11-12-5-7-13(21)8-6-12)16(25)4-2-3-14(18(28)29)22-20(32)23-15(19(30)31)9-10-17(26)27/h5-8,14-15H,2-4,9-11H2,1H3,(H,26,27)(H,28,29)(H,30,31)(H2,22,23,32)/t14-,15-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 0.640 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM578390
(US11478558, Compound 2)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCN(Cc1ccc(Br)cc1)C(=O)CCCCNC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1)C(O)=O)C(O)=O |r| | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 0.640 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description TBD |
Citation and Details
BindingDB Entry DOI: 10.7270/Q20P138Q |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50503760
(CHEMBL4442450)Show SMILES CC(C)C[C@H](NC(=O)O[C@@H](CCC(O)=O)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C12H19NO8/c1-6(2)5-7(10(16)17)13-12(20)21-8(11(18)19)3-4-9(14)15/h6-8H,3-5H2,1-2H3,(H,13,20)(H,14,15)(H,16,17)(H,18,19)/t7-,8-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid PDB UniChem
| PDB Article PubMed
| n/a | n/a | 0.650 | n/a | n/a | n/a | n/a | n/a | n/a |
Institute of Biotechnology of the Czech Academy of Sciences
Curated by ChEMBL
| Assay Description Inhibition of N-terminally tagged human recombinant GCP2 (44 to 750 residues) extracellular domain expressed in Drosophila melanogaster S2 cells prei... |
Bioorg Med Chem 27: 255-264 (2019)
Article DOI: 10.1016/j.bmc.2018.11.022 BindingDB Entry DOI: 10.7270/Q2F47SC4 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50222546
(CHEMBL241779 | tetralithium (2S)-2-(phosphonatoami...)Show SMILES [O-]C(=O)CC[C@H](NP([O-])([O-])=O)C([O-])=O Show InChI InChI=1S/C5H10NO7P/c7-4(8)2-1-3(5(9)10)6-14(11,12)13/h3H,1-2H2,(H,7,8)(H,9,10)(H3,6,11,12,13)/p-4/t3-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL KEGG PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 0.860 | n/a | n/a | n/a | n/a | n/a | n/a |
San Francisco State University
Curated by ChEMBL
| Assay Description Inhibition of PSMA |
Bioorg Med Chem 15: 7434-43 (2007)
Article DOI: 10.1016/j.bmc.2007.07.028 BindingDB Entry DOI: 10.7270/Q2057FMF |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468180
(CHEMBL4294773)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)NCCNC(=O)c1ccc(F)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C21H27FN4O9/c22-13-6-4-12(5-7-13)18(30)24-11-10-23-16(27)3-1-2-14(19(31)32)25-21(35)26-15(20(33)34)8-9-17(28)29/h4-7,14-15H,1-3,8-11H2,(H,23,27)(H,24,30)(H,28,29)(H,31,32)(H,33,34)(H2,25,26,35)/t14-,15-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 0.940 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468170
(CHEMBL4292853)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)Nc1ccc(F)nc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C17H21FN4O8/c18-12-6-4-9(8-19-12)20-13(23)3-1-2-10(15(26)27)21-17(30)22-11(16(28)29)5-7-14(24)25/h4,6,8,10-11H,1-3,5,7H2,(H,20,23)(H,24,25)(H,26,27)(H,28,29)(H2,21,22,30)/t10-,11-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid PDB UniChem
| PDB Article PubMed
| n/a | n/a | 0.990 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468168
(CHEMBL4291603)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)NCCNC(=O)c1ccc(F)nc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C20H26FN5O9/c21-14-6-4-11(10-24-14)17(30)23-9-8-22-15(27)3-1-2-12(18(31)32)25-20(35)26-13(19(33)34)5-7-16(28)29/h4,6,10,12-13H,1-3,5,7-9H2,(H,22,27)(H,23,30)(H,28,29)(H,31,32)(H,33,34)(H2,25,26,35)/t12-,13-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM17659
((R,S)-2-phosphonomethylpentanedioic acid | 2-(phos...)Show InChI InChI=1S/C6H11O7P/c7-5(8)2-1-4(6(9)10)3-14(11,12)13/h4H,1-3H2,(H,7,8)(H,9,10)(H2,11,12,13) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer HealthCare
Curated by ChEMBL
| Assay Description Inhibition of NAALADase activity in human LNCaP cell membranes assessed as inhibition of [3H]NAG conversion to [3H]glutamate after 30 mins by liquid ... |
J Med Chem 55: 9510-20 (2012)
Article DOI: 10.1021/jm300710j BindingDB Entry DOI: 10.7270/Q28053R3 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468169
(CHEMBL4281573)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)NC(c1ccc(F)cc1)c1ccc(F)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C25H27F2N3O8/c26-16-8-4-14(5-9-16)22(15-6-10-17(27)11-7-15)30-20(31)3-1-2-18(23(34)35)28-25(38)29-19(24(36)37)12-13-21(32)33/h4-11,18-19,22H,1-3,12-13H2,(H,30,31)(H,32,33)(H,34,35)(H,36,37)(H2,28,29,38)/t18-,19-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM456920
(US10736974, Entry 23)Show SMILES CSc1ccc(cc1)C(=O)NCCCC(=O)N[C@H](CNC(=O)N[C@@H](CCC(O)=O)C(O)=O)OC=O |r| Show InChI InChI=1S/C21H28N4O9S/c1-35-14-6-4-13(5-7-14)19(30)22-10-2-3-16(27)25-17(34-12-26)11-23-21(33)24-15(20(31)32)8-9-18(28)29/h4-7,12,15,17H,2-3,8-11H2,1H3,(H,22,30)(H,25,27)(H,28,29)(H,31,32)(H2,23,24,33)/t15-,17-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
THE JOHNS HOPKINS UNIVERSITY
US Patent
| Assay Description The PSMA inhibitory activity was determined using a modification of the fluorescence-based Amplex Red Glutamic Acid Assay. Briefly, lysates of LNCaP ... |
US Patent US10736974 (2020)
BindingDB Entry DOI: 10.7270/Q29C71GJ |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50544832
(CHEMBL4636677)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)COc1ccc(C[C@H](NC(=O)CNC(=O)c2ccc(I)cc2)C(O)=O)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C41H47IN6O14/c42-27-13-11-26(12-14-27)36(53)44-22-33(49)46-32(40(59)60)21-25-9-15-28(16-10-25)62-23-34(50)45-31(20-24-6-2-1-3-7-24)37(54)43-19-5-4-8-29(38(55)56)47-41(61)48-30(39(57)58)17-18-35(51)52/h1-3,6-7,9-16,29-32H,4-5,8,17-23H2,(H,43,54)(H,44,53)(H,45,50)(H,46,49)(H,51,52)(H,55,56)(H,57,58)(H,59,60)(H2,47,48,61)/t29-,30-,31-,32-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Beijing Normal University
Curated by ChEMBL
| Assay Description Displacement of [125I]MIP-1095 from PSMA in human PC3-PIP cells after 1 hr by gamma counter analysis |
Bioorg Med Chem 28: (2020)
Article DOI: 10.1016/j.bmc.2020.115319 BindingDB Entry DOI: 10.7270/Q2CF9TPT |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468172
(CHEMBL4289458)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)N1CCN(CC1)c1ccc(F)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C22H29FN4O8/c23-14-4-6-15(7-5-14)26-10-12-27(13-11-26)18(28)3-1-2-16(20(31)32)24-22(35)25-17(21(33)34)8-9-19(29)30/h4-7,16-17H,1-3,8-13H2,(H,29,30)(H,31,32)(H,33,34)(H2,24,25,35)/t16-,17-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50592344
(CHEMBL5205430)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCN(Cc1cccc(Cl)c1)C(=O)CCCCCNC(=O)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)c(c1)[N+]([O-])=O)C(=O)NCCCN=[N+]=[N-])C(O)=O)C(O)=O |r| | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.128840 BindingDB Entry DOI: 10.7270/Q2DR30GB |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50514660
(Dcfpyl | US10894807, ID P002)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)c1ccc(F)nc1)C(O)=O)C(O)=O Show InChI InChI=1S/C18H23FN4O8/c19-13-6-4-10(9-21-13)15(26)20-8-2-1-3-11(16(27)28)22-18(31)23-12(17(29)30)5-7-14(24)25/h4,6,9,11-12H,1-3,5,7-8H2,(H,20,26)(H,24,25)(H,27,28)(H,29,30)(H2,22,23,31)/t11-,12-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
MCE PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Korea University
Curated by ChEMBL
| Assay Description Inhibition of PSMA in human LNCaP cell extracts in presence of N-acetylaspartylglutamate by Amplex red glutamic acid dependent fluorescence-based NAA... |
J Med Chem 63: 3261-3273 (2020)
Article DOI: 10.1021/acs.jmedchem.9b02022 BindingDB Entry DOI: 10.7270/Q232007C |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM456914
(US10736974, Compound XY-43 | US10736974, Entry 17)Show SMILES OC(=O)CC[C@H](NC(=O)O[C@@H](CCCCNC(=O)c1ccc(I)cc1F)OC=O)C(O)=O |r| Show InChI InChI=1S/C19H22FIN2O9/c20-13-9-11(21)4-5-12(13)17(27)22-8-2-1-3-16(31-10-24)32-19(30)23-14(18(28)29)6-7-15(25)26/h4-5,9-10,14,16H,1-3,6-8H2,(H,22,27)(H,23,30)(H,25,26)(H,28,29)/t14-,16-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a |
THE JOHNS HOPKINS UNIVERSITY
US Patent
| Assay Description The PSMA inhibitory activity was determined using a modification of the fluorescence-based Amplex Red Glutamic Acid Assay. Briefly, lysates of LNCaP ... |
US Patent US10736974 (2020)
BindingDB Entry DOI: 10.7270/Q29C71GJ |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50358647
(CHEMBL1921900)Show SMILES OC(=O)CC[C@H](NP(O)(=O)OC[C@H](NC(=O)CC[C@H](NC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(c(c1)C(O)=O)-c1c2ccc(O)cc2oc2cc(=O)ccc12)C(O)=O)C(O)=O)C(O)=O |r,wD:18.18,12.12,5.5,(58.79,-21.53,;58.78,-20,;60.12,-19.23,;57.45,-19.23,;56.12,-20,;54.79,-19.23,;53.46,-20,;52.12,-19.23,;53.21,-18.14,;50.79,-20,;52.12,-17.69,;50.79,-16.92,;50.79,-15.39,;49.45,-14.61,;48.13,-15.38,;48.13,-16.92,;46.79,-14.61,;45.47,-15.38,;44.13,-14.61,;42.8,-15.38,;41.47,-14.61,;41.47,-13.08,;40.14,-15.38,;38.8,-14.61,;37.48,-15.38,;36.14,-14.62,;34.81,-15.39,;33.48,-14.62,;32.15,-15.39,;30.81,-14.62,;29.48,-15.39,;28.15,-14.62,;26.82,-15.39,;25.49,-14.62,;24.15,-15.39,;22.82,-14.62,;21.49,-15.39,;20.16,-14.62,;18.82,-15.39,;17.5,-14.62,;16.16,-15.39,;14.83,-14.63,;13.5,-15.39,;12.17,-14.63,;10.83,-15.4,;9.51,-14.63,;8.17,-15.4,;6.84,-14.63,;5.51,-15.4,;4.18,-14.63,;2.84,-15.4,;4.18,-13.09,;2.84,-12.32,;2.84,-10.78,;4.18,-10.02,;5.51,-10.78,;5.51,-12.31,;6.84,-10.01,;8.17,-10.77,;5.73,-8.91,;4.18,-8.47,;2.86,-7.71,;1.53,-8.48,;.19,-7.71,;.2,-6.17,;-1.14,-5.41,;1.52,-5.4,;2.85,-6.16,;4.19,-5.39,;5.53,-6.17,;6.85,-5.4,;8.19,-6.18,;9.52,-5.42,;8.18,-7.72,;6.84,-8.48,;5.52,-7.71,;44.13,-13.07,;45.47,-12.31,;42.8,-12.3,;52.12,-14.62,;53.46,-15.38,;52.12,-13.07,;54.79,-17.68,;56.12,-16.91,;53.45,-16.91,)| Show InChI InChI=1S/C53H69N4O27P/c58-34-2-5-37-43(30-34)84-44-31-35(59)3-6-38(44)48(37)36-4-1-33(29-39(36)50(65)66)49(64)54-12-14-76-16-18-78-20-22-80-24-26-82-28-27-81-25-23-79-21-19-77-17-15-75-13-11-46(61)55-40(51(67)68)7-9-45(60)56-42(53(71)72)32-83-85(73,74)57-41(52(69)70)8-10-47(62)63/h1-6,29-31,40-42,58H,7-28,32H2,(H,54,64)(H,55,61)(H,56,60)(H,62,63)(H,65,66)(H,67,68)(H,69,70)(H,71,72)(H2,57,73,74)/t40-,41-,42-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.93 | n/a | n/a | n/a | n/a | n/a | n/a |
Washington State University
Curated by ChEMBL
| Assay Description Inhibition of PSMA using N-[4-(phenylazo)-benzoyl]-glutamyl-gamma-glutamic acid as substrate after 15 mins by HPLC analysis |
Bioorg Med Chem Lett 21: 7013-6 (2011)
Article DOI: 10.1016/j.bmcl.2011.09.115 BindingDB Entry DOI: 10.7270/Q2PG1S5S |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50392045
(CHEMBL2152561)Show InChI InChI=1S/C16H14O4S/c17-15(18)12-5-1-4-11(9-12)13-6-2-3-10(7-8-21)14(13)16(19)20/h1-6,9,21H,7-8H2,(H,17,18)(H,19,20) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Eisai Inc.
Curated by ChEMBL
| Assay Description Inhibition of human recombinant GCP2 using N-acetyl-L-aspartyl-[3H]-L-glutamate as substrate by microplate assay |
J Med Chem 55: 5922-32 (2012)
Article DOI: 10.1021/jm300488m BindingDB Entry DOI: 10.7270/Q21J9BWN |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50265453
((S)-2-(3-((S)-1-Carboxy-5-(3-(4-bromophenyl)ureido...)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)Nc1ccc(Br)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C19H25BrN4O8/c20-11-4-6-12(7-5-11)22-18(31)21-10-2-1-3-13(16(27)28)23-19(32)24-14(17(29)30)8-9-15(25)26/h4-7,13-14H,1-3,8-10H2,(H,25,26)(H,27,28)(H,29,30)(H2,21,22,31)(H2,23,24,32)/t13-,14-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Molecular Insight Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of [131I]DCIT from PSMA in human LNCAP cells |
J Med Chem 52: 347-57 (2009)
Article DOI: 10.1021/jm800994j BindingDB Entry DOI: 10.7270/Q2V987ZZ |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50265381
((S)-2-(3-((S)-1-Carboxy-5-(4-chlorobenzylamino)pen...)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNCc1ccc(Cl)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C19H26ClN3O7/c20-13-6-4-12(5-7-13)11-21-10-2-1-3-14(17(26)27)22-19(30)23-15(18(28)29)8-9-16(24)25/h4-7,14-15,21H,1-3,8-11H2,(H,24,25)(H,26,27)(H,28,29)(H2,22,23,30)/t14-,15-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Molecular Insight Pharmaceuticals, Inc.
Curated by ChEMBL
| Assay Description Inhibition of [131I]DCIT from PSMA in human LNCAP cells |
J Med Chem 52: 347-57 (2009)
Article DOI: 10.1021/jm800994j BindingDB Entry DOI: 10.7270/Q2V987ZZ |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50392040
(CHEMBL2152556)Show InChI InChI=1S/C16H14O5S/c17-15(18)12-3-1-2-10(6-12)8-21-14-5-4-11(9-22)7-13(14)16(19)20/h1-7,22H,8-9H2,(H,17,18)(H,19,20) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Eisai Inc.
Curated by ChEMBL
| Assay Description Inhibition of human recombinant GCP2 using N-acetyl-L-aspartyl-[3H]-L-glutamate as substrate by microplate assay |
J Med Chem 55: 5922-32 (2012)
Article DOI: 10.1021/jm300488m BindingDB Entry DOI: 10.7270/Q21J9BWN |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM456921
(US10736974, Entry 24)Show SMILES OC(=O)CC[C@H](NC(=O)NC[C@@H](NC(=O)CCCNC(=O)c1ccc(cc1F)-c1ccccc1)OC=O)C(O)=O |r| Show InChI InChI=1S/C26H29FN4O9/c27-19-13-17(16-5-2-1-3-6-16)8-9-18(19)24(36)28-12-4-7-21(33)31-22(40-15-32)14-29-26(39)30-20(25(37)38)10-11-23(34)35/h1-3,5-6,8-9,13,15,20,22H,4,7,10-12,14H2,(H,28,36)(H,31,33)(H,34,35)(H,37,38)(H2,29,30,39)/t20-,22-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
THE JOHNS HOPKINS UNIVERSITY
US Patent
| Assay Description The PSMA inhibitory activity was determined using a modification of the fluorescence-based Amplex Red Glutamic Acid Assay. Briefly, lysates of LNCaP ... |
US Patent US10736974 (2020)
BindingDB Entry DOI: 10.7270/Q29C71GJ |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50544834
(CHEMBL4636963)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)c1ccc(I)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C38H47IN6O15/c39-23-11-9-22(10-12-23)32(52)41-24(13-16-29(46)47)34(54)42-25(14-17-30(48)49)35(55)43-28(20-21-6-2-1-3-7-21)33(53)40-19-5-4-8-26(36(56)57)44-38(60)45-27(37(58)59)15-18-31(50)51/h1-3,6-7,9-12,24-28H,4-5,8,13-20H2,(H,40,53)(H,41,52)(H,42,54)(H,43,55)(H,46,47)(H,48,49)(H,50,51)(H,56,57)(H,58,59)(H2,44,45,60)/t24-,25-,26-,27-,28-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Beijing Normal University
Curated by ChEMBL
| Assay Description Displacement of [125I]MIP-1095 from PSMA in human PC3-PIP cells after 1 hr by gamma counter analysis |
Bioorg Med Chem 28: (2020)
Article DOI: 10.1016/j.bmc.2020.115319 BindingDB Entry DOI: 10.7270/Q2CF9TPT |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468171
(CHEMBL4294649)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)NCc1ccccc1F)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C19H24FN3O8/c20-12-5-2-1-4-11(12)10-21-15(24)7-3-6-13(17(27)28)22-19(31)23-14(18(29)30)8-9-16(25)26/h1-2,4-5,13-14H,3,6-10H2,(H,21,24)(H,25,26)(H,27,28)(H,29,30)(H2,22,23,31)/t13-,14-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50592343
(CHEMBL5202039)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCN(Cc1ccc(cc1)C(O)=O)C(=O)CCCCCNC(=O)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)c(c1)[N+]([O-])=O)C(=O)NCCCN=[N+]=[N-])C(O)=O)C(O)=O |r| | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
Article DOI: 10.1016/j.bmcl.2022.128840 BindingDB Entry DOI: 10.7270/Q2DR30GB |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM578391
(US11478558, Compound 3)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)CCCCNC(=S)Nc1ccc(CC2CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CCN2CC(O)=O)cc1)C(O)=O)C(O)=O |r| | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.16 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description TBD |
Citation and Details
BindingDB Entry DOI: 10.7270/Q20P138Q |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50468179
(CHEMBL4279502)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCC(=O)NCc1ccc(F)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C19H24FN3O8/c20-12-6-4-11(5-7-12)10-21-15(24)3-1-2-13(17(27)28)22-19(31)23-14(18(29)30)8-9-16(25)26/h4-7,13-14H,1-3,8-10H2,(H,21,24)(H,25,26)(H,27,28)(H,29,30)(H2,22,23,31)/t13-,14-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid PDB UniChem
| PDB Article PubMed
| n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Illinois at Chicago
Curated by ChEMBL
| Assay Description Inhibition of recombinant human PSMA using [3H]NAAG as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins by li... |
ACS Med Chem Lett 9: 1099-1104 (2018)
Article DOI: 10.1021/acsmedchemlett.8b00318 BindingDB Entry DOI: 10.7270/Q2Q81GSC |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50222549
((S)-2-phosphonoamino-pentanedioic acid | CHEMBL238...)Show InChI InChI=1S/C5H10NO7P/c7-4(8)2-1-3(5(9)10)6-14(11,12)13/h3H,1-2H2,(H,7,8)(H,9,10)(H3,6,11,12,13)/t3-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL KEGG PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | n/a | n/a |
San Francisco State University
Curated by ChEMBL
| Assay Description Inhibition of PSMA |
Bioorg Med Chem 15: 7434-43 (2007)
Article DOI: 10.1016/j.bmc.2007.07.028 BindingDB Entry DOI: 10.7270/Q2057FMF |
More data for this Ligand-Target Pair | |
Glutamate carboxypeptidase 2
(Homo sapiens (Human)) | BDBM50544835
(CHEMBL4649277)Show SMILES OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(O)=O)NC(=O)c1ccc(I)cc1)C(O)=O)C(O)=O |r| Show InChI InChI=1S/C33H40IN5O12/c34-21-11-9-20(10-12-21)28(44)36-22(13-15-26(40)41)30(46)37-25(18-19-6-2-1-3-7-19)29(45)35-17-5-4-8-23(31(47)48)38-33(51)39-24(32(49)50)14-16-27(42)43/h1-3,6-7,9-12,22-25H,4-5,8,13-18H2,(H,35,45)(H,36,44)(H,37,46)(H,40,41)(H,42,43)(H,47,48)(H,49,50)(H2,38,39,51)/t22-,23-,24-,25-/m0/s1 | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Beijing Normal University
Curated by ChEMBL
| Assay Description Displacement of [125I]MIP-1095 from PSMA in human PC3-PIP cells after 1 hr by gamma counter analysis |
Bioorg Med Chem 28: (2020)
Article DOI: 10.1016/j.bmc.2020.115319 BindingDB Entry DOI: 10.7270/Q2CF9TPT |
More data for this Ligand-Target Pair | |